An event of embolization of the 18mm occluder with subsequent implant of a larger, 24mm device was reported.The results of the investigation are inconclusive since the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications at the time of commercialization.Based on the information received, the device was potentially undersized; however, the extent to which this contributed to the subsequent embolization could not be conclusively determined.Information from the field indicated that the device was removed 1 month after embolization.Please note, per the instructions for use artmt100116885 rev.A, "embolized devices must be removed because they may cause patient harm.Embolized devices should not be withdrawn through intracardiac structures unless they have been collapsed within a sheath.".
|
On (b)(6) 2020, an 18 mm amplatzer septal occluder was implanted.The following day, the device embolized to the left atrium.The patient did not present any symptoms.On (b)(6), the physician removed the embolized device percutaneously.On (b)(6), a 24mm amplatzer septal occluder was successfully implanted.The patient is currently stable.
|